The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-N-phenyl-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)nicotinamide ID: ALA4782872
PubChem CID: 162664001
Max Phase: Preclinical
Molecular Formula: C20H22N6O
Molecular Weight: 362.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C20H22N6O/c21-19-18(20(27)25-16-4-2-1-3-5-16)10-14(11-23-19)15-12-24-26(13-15)17-6-8-22-9-7-17/h1-5,10-13,17,22H,6-9H2,(H2,21,23)(H,25,27)
Standard InChI Key: YJSVSSSRRSTHBV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
5.9377 -1.6137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9365 -2.4332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6446 -2.8422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3542 -2.4328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3514 -1.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6428 -1.2048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2289 -2.8386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4826 -2.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3434 -3.8206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1428 -3.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0626 -2.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0639 -3.6574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7722 -4.0649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7689 -4.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4764 -5.2869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1844 -4.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1805 -4.0557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4724 -3.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0576 -1.1989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9291 -3.1078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1125 -3.0192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7843 -2.2698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9756 -2.1798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4893 -2.8369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8175 -3.5863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6321 -3.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7696 -2.4305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 20 1 0
9 10 2 0
10 7 1 0
2 7 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
5 19 1 0
9 20 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
20 21 1 0
11 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.44Molecular Weight (Monoisotopic): 362.1855AlogP: 2.70#Rotatable Bonds: 4Polar Surface Area: 97.86Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.12CX LogP: 1.98CX LogD: -0.63Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -1.20
References 1. May-Dracka TL,Arduini R,Bertolotti-Ciarlet A,Bhisetti G,Brickelmaier M,Cahir-McFarland E,Enyedy I,Fontenot JD,Hesson T,Little K,Lyssikatos J,Marcotte D,McKee T,Murugan P,Patterson T,Peng H,Rushe M,Silvian L,Spilker K,Wu P,Xin Z,Burkly LC. (2018) Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity., 28 (10): [PMID:29636220 ] [10.1016/j.bmcl.2018.03.032 ]